Evidence map›Paper›PMID 24052457›Full record

ArticleNeurocritical care2014

Serotonin syndrome in the intensive care unit: clinical presentations and precipitating medications.

Swetha Pedavally, Jennifer E Fugate, Alejandro A Rabinstein

Abstract read
PubMed Publisher
In one paragraph

Article in Neurocritical care, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Linezolid and serotonin syndrome.The Journal of international medical research · 2025
    Review
  3. Article
  4. Serotonin syndrome controversies: A need for consensus.World journal of critical care medicine · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Serotonin-Its Synthesis and Roles in the Healthy and the Critically Ill.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Serotonin Syndrome in ICU-A Road Less Traveled.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2019
    Article
  13. Serotonin Syndrome in the Perioperative Setting.The American journal of case reports · 2018
    Article
  14. Review
  15. Unsuspected serotonin toxicity in the ICU.Annals of intensive care · 2016
    Article
  16. Article
  17. Neurologic Complications of Commonly Used Drugs in the Hospital Setting.Current neurology and neuroscience reports · 2016
    Review
  18. Effects of opioids on human serotonin transporters.Naunyn-Schmiedeberg's archives of pharmacology · 2015
    Article
  19. Changes in intensity of serotonin syndrome caused by adverse interaction between monoamine oxidase inhibitors and serotonin reuptake blockers.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2014
    Article
  20. Serotonin syndrome: An often-neglected medical emergency.Journal of family & community medicine
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Swetha PedavallyDivision of Neurocritical Care, Department of Neurology, Mayo Clinic, 200 First Street SW, Mayo W8B, Rochester, MN, 55905, USA.
Jennifer E Fugate
Alejandro A Rabinstein
Mayo Clinic · USWinnMed · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerotonin syndrome (SS) is becoming a more frequent diagnosis in the intensive care unit (ICU). We sought to determine the clinical presentation, drug exposures, and outcomes of SS in critically ill patients.

methodsA retrospective study of 33 consecutive ICU patients with SS between March 2007 and March 2012 in ICUs in a large teaching hospital. SS was defined using the Hunter Serotonin Toxicity Criteria.

resultsSeventeen patients (52%) were admitted for mental status changes, including seven patients (21%) with drug overdose and four cases (12%) in which SS was considered the primary admission diagnosis. In 13 patients (39%) the features of SS developed only after a mean of 6.8 ± 9 days of hospitalization. Most received multiple serotonergic drugs upon diagnosis (median three drugs, range 1-5). Antidepressants were the serotonergic medications most often used before admission, and opioids (principally fentanyl) and antiemetics were the most frequently prescribed new serotonin-enhancing medications. Altered mental status was present in all patients and myoclonus, rigidity, and hyperreflexia were the most prevalent examination signs. All but one patient had documented recovery. The mean time to neurological improvement was 56 ± 5 h, but ranged from 8 to 288 h. There were no cases of renal failure related to rhabdomyolysis, or death or persistent disability caused by SS.

conclusionSS in the ICU occurs most often because of exposure to multiple serotonergic agents. Continuation of antidepressants plus the addition of opioids and antiemetics during hospitalization are most commonly responsible for this complication.

Indexed as

AdolescentAdultAgedAntiemeticsFemaleHumansIntensive Care UnitsMaleMiddle AgedNarcoticsSerotonin AgentsSerotonin SyndromeYoung AdultAntiemeticsNarcoticsSerotonin Agents

Identifiers

PMID24052457
OpenAlexW2112276409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.